The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

By Pal Sumanta  

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 5-16

Springer Publishing Company

Access to resources Recommend Favorite

Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors

By Raymond Eric   Hobday Timothy   Castellano Daniel   Reidy-Lagunes Diane   García-Carbonero Rocío   Carrato Alfredo  

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 19-26

Springer Publishing Company

Access to resources Recommend Favorite

The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas

By Vemulapalli Sushma  

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 29-39

Springer Publishing Company

Access to resources Recommend Favorite

Updates of mTOR Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 7, 2010-09 ,pp. : 571-581

Bentham Science Publishers

Access to resources Recommend Favorite